Nagle Christina M, Purdie David M, Webb Penelope M, Green Adèle C, Bain Christopher J
School of Population Health, University of Queensland Medical School, Herston, Queensland 4006, Australia.
Asian Pac J Cancer Prev. 2006 Jan-Mar;7(1):41-5.
To compare the accuracy, costs and utility of using the National Death Index (NDI) and state-based cancer registries in determining the mortality status of a cohort of women diagnosed with ovarian cancer in the early 1990s.
As part of a large prognostic study, identifying information on 822 women diagnosed with ovarian cancer between 1990 and 1993, was simultaneously submitted to the NDI and three state-based cancer registries to identify deceased women as of June 30, 1999. This was compared to the gold standard of "definite deaths". A comparative evaluation was also made of the time and costs associated with the two methods.
Of the 450 definite deaths in our cohort the NDI correctly identified 417 and all of the 372 women known to be alive (sensitivity 93%, specificity 100%). Inconsistencies in identifiers recorded in our cohort files, particularly names, were responsible for the majority of known deaths not matching with the NDI, and if eliminated would increase the sensitivity to 98%. The cancer registries correctly identified 431 of the 450 definite deaths (sensitivity 96%). The costs associated with the NDI search were the same as the cancer registry searches, but the cancer registries took two months longer to conduct the searches.
This study indicates that the cancer registries are valuable, cost effective agencies for follow-up of mortality outcome in cancer cohorts, particularly where cohort members were residents of those states. For following large national cohorts the NDI provides additional information and flexibility when searching for deaths in Australia. This study also shows that women can be followed up for mortality with a high degree of accuracy using either service. Because each service makes a valuable contribution to the identification of deceased cancer subjects, both should be considered for optimal mortality follow-up in studies of cancer patients.
比较使用国家死亡指数(NDI)和基于州的癌症登记处来确定20世纪90年代初被诊断为卵巢癌的一组女性的死亡状态时的准确性、成本和实用性。
作为一项大型预后研究的一部分,关于1990年至1993年间被诊断为卵巢癌的822名女性的识别信息,同时提交给了NDI和三个基于州的癌症登记处,以确定截至1999年6月30日已死亡的女性。将其与“确定死亡”的金标准进行比较。还对两种方法相关的时间和成本进行了比较评估。
在我们的队列中的450例确定死亡病例中,NDI正确识别出417例,并且已知存活的372名女性全部被正确识别(敏感性93%,特异性100%)。我们队列文件中记录的标识符不一致,尤其是姓名,是导致大多数已知死亡病例与NDI不匹配的原因,如果消除这些不一致因素,敏感性将提高到98%。癌症登记处正确识别出450例确定死亡病例中的431例(敏感性96%)。与NDI搜索相关的成本与癌症登记处搜索的成本相同,但癌症登记处进行搜索花费的时间要长两个月。
本研究表明,癌症登记处是癌症队列死亡结局随访的有价值、具有成本效益的机构,特别是当队列成员是那些州的居民时。对于追踪大型全国性队列,在澳大利亚搜索死亡信息时,NDI提供了额外的信息和灵活性。本研究还表明,使用这两种服务中的任何一种都可以以高度的准确性对女性进行死亡随访。由于每种服务在识别已故癌症患者方面都做出了宝贵贡献,在癌症患者研究中进行最佳死亡随访时应同时考虑这两种服务。